Skip to main content
. 2026 Feb 26;13(3):331. doi: 10.3390/children13030331
BPD Bronchopulmonary dysplasia
CHD Congenital heart defects
CLD Chronic lung disease
CRST Canadian Risk Scoring Tool
EMA European Medicines Agency
FDA Food and Drug Administration
ICERs Incremental cost-effectiveness ratios
ICU Intensive care unit
IRST International Risk Scoring Tool
LRTI Lower respiratory tract infections
nAb Neutralizing antibody
QALY Cost per quality-adjusted life year
RCTs randomized controlled trials
RSV Respiratory syncytial virus